STING1 and neoplasm: Cyclic dinucleotide agonists, such as 2′5′-cGAMP, can enhance the activation level of STING proteins and activate the cGAS/STING signaling pathway in neighboring cells via transport vesicles as well as intercellular junctions, thereby improving immune recognition of viral particles or tumor cells (56, 57).